<i>Bifidobacterium animalis</i> subsp. <i>lactis F1–7</i> Alleviates Lipid Accumulation in Atherosclerotic Mice via Modulating Bile Acid Metabolites to Downregulate Intestinal FXR-Reference-Cited by-同舟云学术

Bifidobacterium animalis subsp. lactis F1–7 Alleviates Lipid Accumulation in Atherosclerotic Mice via Modulating Bile Acid Metabolites to Downregulate Intestinal FXR

Published:2024-01-29 Issue:5 Volume:72 Page:2585-2597
ISSN:0021-8561
Container-title:Journal of Agricultural and Food Chemistry
language:en
Short-container-title:J. Agric. Food Chem.

Author:

Liang Xi¹,Zheng Xiumei¹,Wang Peng¹^ORCID,Zhang Huaqi¹,Ma Yiqing¹,Liang Hui¹^ORCID,Zhang Zhe²^ORCID

Affiliation:

1. Department of Nutrition and Food Hygiene, School of Public Health, Qingdao University, Qingdao 266100, Shandong China

2. College of Food Science and Engineering, Ocean University of China, Qingdao 266003, Shandong China

Funder

Qingdao Postdoctoral Science Foundation

Shandong Provincial Natural Science Foundation

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jafc.3c05709

Reference48 articles.

1. Hyperlipidemia induces typical atherosclerosis development in Ldlr and Apoe deficient rats

2. Lipoprotein lipase: Biosynthesis, regulatory factors, and its role in atherosclerosis and other diseases

3. Bile Acids as Metabolic Regulators and Nutrient Sensors

4. Implication of gut microbiota metabolites in cardiovascular and metabolic diseases

5. Farnesoid-X Receptor (FXR) as a Promising Pharmaceutical Target in Atherosclerosis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the role of a novel postbiotic bile acid: Interplay with gut microbiota, modulation of the farnesoid X receptor, and prospects for clinical translation;Microbiological Research;2024-10

2. Gut Microbiota and Its Metabolites: The Emerging Bridge Between Coronary Artery Disease and Anxiety and Depression?;aging and disease;2024